GENZYME
Genzyme Corporation (Genzyme) is a biotechnology company. The Company's product and service portfolio is focused on rare genetic disease disorders, renal diseases, orthopaedics, cancer, transplant and immune disease. Genzyme operates in four business segments: Genetic Diseases, Cardiometabolic and Renal, Biosurgery and Hematologic Oncology. Genetic Diseases unit develops, manufactures and distributes therapeutic products, with a focus on products to treat patients suffering from genetic diseases... , including a family of diseases known as lysosomal storage disorders (LSDs). Cardiometabolic and Renal segment develops, manufactures and distributes products that treat patients suffering from renal diseases, including chronic renal failure and endocrine and cardiovascular diseases. Biosurgery develops, manufactures and distributes biotherapeutics and biomaterial-based products. Hematologic Oncology develops, manufactures and distributes products for the treatment of cancer.
GENZYME
Industry:
Biopharma Biotechnology Genetics
Founded:
1981-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.genzyme.com
Total Employee:
10001+
Status:
Active
Contact:
6177686618
Technology used in webpage:
Domain Not Resolving Google Maps AJAX Libraries API JQuery CDN ASP.NET Ajax Facebook Like Button Apple Whitelist ShareThis The Trade Desk ComScore
Similar Organizations
LC Sciences
LC Sciences is a biotech company that provides products and services to genomics and proteomics researchers.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Current Advisors List
Current Employees Featured
Founder
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2007-05-29 | Bioenvision | Bioenvision acquired by Genzyme | 345 M USD |
| 2006-10-17 | AnorMED | AnorMED acquired by Genzyme | 580 M USD |
| 2005-07-01 | BoneCare International | BoneCare International acquired by Genzyme | 719 M USD |
| 2005-02-09 | Verigen | Verigen acquired by Genzyme | N/A |
| 2004-12-20 | ILEX Oncology,Inc. | ILEX Oncology,Inc. acquired by Genzyme | 1000 M USD |
| 2003-09-10 | SangStat | SangStat acquired by Genzyme | N/A |
| 2000-12-18 | Biomatrix | Biomatrix acquired by Genzyme | 738 M USD |
| 1997-06-16 | Pharmagenics | Pharmagenics acquired by Genzyme | 28 M USD |
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2015-02-11 | Voyager Therapeutics | Genzyme investment in Corporate Round - Voyager Therapeutics | 30 M USD |
| 2014-01-13 | Alnylam Pharmaceuticals | Genzyme investment in Post-IPO Equity - Alnylam Pharmaceuticals | 700 M USD |
| 2008-09-23 | Humanigen | Genzyme investment in Series D - Humanigen | 20 M USD |
| 2006-06-07 | Peptimmune | Genzyme investment in Series C - Peptimmune | 12 M USD |
Newest Events participated
Participated in 3rd World Congress on Thyroid Cancer
on 2017-07-27 as exhibitor
Official Site Inspections
http://www.genzyme.com
- Host name: ec2-54-247-151-159.eu-west-1.compute.amazonaws.com
- IP address: 54.247.151.159
- Location: Dublin Ireland
- Latitude: 53.3338
- Longitude: -6.2488
- Timezone: Europe/Dublin
- Postal: D02
More informations about "Genzyme"
Genzyme Corporation - Org Chart, Teams, Culture
Genzyme Corporation (Genzyme) is a biotechnology company. The Company's product and service portfolio is focused on rare genetic disease. Industries. Hospital. Headquarters. Cambridge, United States. Employees. 10,000+ …See details»
Genzyme - Crunchbase Company Profile & Funding
Genzyme operates in four business segments: Genetic Diseases, Cardiometabolic and Renal, Biosurgery and Hematologic Oncology. Genetic Diseases unit develops, manufactures and distributes therapeutic products, …See details»
Sanofi Genzyme - Crunchbase Company Profile
Sanofi Genzyme is the specialty care global business unit of Sanofi, focused on rare diseases, multiple sclerosis, immunology, and oncology. They help people with debilitating and complex conditions that are often difficult to diagnose and …See details»
Genzyme Corporation -- Company History
Genzyme Corporation is a leading biotechnology company that focuses on five business areas: therapeutics, diagnostic services, diagnostic products, pharmaceutical and fine chemicals, and …See details»
Genzyme Corporation's Leadership Team Team - The Org
Genzyme Corporation's Leadership Team includes Mark Underwood and 20 others. Team members. Adam Gluck. Head of Sanofi U.S. and Sanofi... Aimee Christian. Global …See details»
Genzyme Corporation's CEO and Executive Team - The Org
EVP and Head of Sanofi Genzyme. Brendan O’callaghan. SVP for Biologics within Indus... Thierry Vernier. Global Head of Finance for San... Other teams at Genzyme Corporation. View all +18. …See details»
Genzyme Corporation Company Profile - Dun & Bradstreet
Company Description: Sanofi Genzyme (formerly Genzyme) makes it way battling uncommon diseases. The company's product portfolio ,focuses on treatments for multiple sclerosis, rare …See details»
Genzyme, a sanofi company Information - RocketReach
Corporate Overview Genzyme has pioneered the development and delivery of transformative therapies for over 30 years. Founded in 1981 in Boston, Massachusetts, Genzyme evolved …See details»
Genzyme - Contacts, Employees, Board Members, Advisors & Alumni
Genzyme has 4 current employee profiles, including Co-Founder George Whitesides. George Whitesides Co-Founder. Jennifer Tengtrakool Manager, Manufacturing Sciences Laboratory. …See details»
GENZYME CORPORATION Company Profile - Dun & Bradstreet
Genzyme corporation. d&b business directory home / business directory / professional, scientific, and technical services / architectural, engineering, and related services / united states / …See details»
Genzyme | Company Overview & News - Forbes
Genzyme Corporation (Genzyme) is a biotechnology company. The Company's product and service portfolio is focused on rare genetic disease disorders, renal diseases, orthopaedics, …See details»
Sanofi Genzyme Company Profile - Office Locations, Competitors …
Sanofi Genzyme (also known as Genzyme Corporation) is a biotech company that specializes in rare diseases, rare blood disorders, multiple sclerosis, oncology, and immunology. It is …See details»
Genzyme Canada Inc Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Genzyme Canada Inc of Mississauga, ON. Get the latest business insights from Dun & Bradstreet.See details»
Eleven years after buying Genzyme, Sanofi officially ditches ... - STAT
Feb 3, 2022 Eleven years after Sanofi bought Genzyme for about $20.1 billion, the parent company said Thursday it will no longer call its specialty care unit Sanofi Genzyme ― just …See details»
Working At Sanofi Genzyme: Company Overview and Culture
Mar 14, 2024 Sanofi Genzyme has great employee retention with staff members usually staying with the company for 5.0 years.The average employee at Sanofi Genzyme makes $84,495 per …See details»
Genzyme Genetics - Crunchbase Company Profile & Funding
Genzyme Genetics is an industry leading provider of reproductive and oncology testing in the United States. Lists Featuring This Company. Edit Lists Featuring This Company Section. …See details»
Genzyme Charitable Foundation - Devex
Genzyme's Community Relations group is dedicated to supporting the communities in which they operate around the world. To that end, it extends grants to non-profit organizations focused on …See details»
Genzyme, a Sanofi Company | European Clinical Trials Information …
Genzyme, a Sanofi Company, is a biotechnology company that specializes in developing treatments for rare diseases. The company was founded in 1981 by Sheridan Snyder and …See details»
Genzyme: 15 Years of Cell and Gene Therapy Research
Feb 1, 1995 Gene therapy. Genzyme initiated research in gene therapy in 1991 with an initial focus on cystic fibrosis (CF). Using its internal expertise in vector technologies, Genzyme …See details»